Results from the Estonian postmenopausal hormone therapy trial [ISRCTN35338757]

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

2002 • 15,184 citations

Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women

1998 • 6,250 citations

Breast cancer and hormone-replacement therapy in the Million Women Study

2003 • 2,896 citations

Estrogen Plus Progestin and the Incidence of Dementia and Mild Cognitive Impairment in Postmenopausal Women

2003 • 2,090 citations

Estrogen plus Progestin and the Risk of Coronary Heart Disease

2003 • 1,998 citations

Cardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy

2002 • 1,922 citations

Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women

2003 • 1,839 citations

Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis

2000 • 1,274 citations

Effects of Estrogen Plus Progestin on Risk of Fracture and Bone Mineral Density<SUBTITLE>The Women's Health Initiative Randomized Trial</SUBTITLE>

2003 • 1,159 citations

Effect of Estrogen Plus Progestin on Stroke in Postmenopausal Women

2003 • 1,146 citations

Postmenopausal Hormone Replacement Therapy

2002 • 986 citations

Effect of Estrogen Plus Progestin on Global Cognitive Function in Postmenopausal Women

2003 • 925 citations

A Clinical Trial of Estrogen-Replacement Therapy after Ischemic Stroke

2001 • 906 citations

Postmenopausal Hormone Therapy Increases Risk for Venous Thromboembolic Disease: The Heart and Estrogen/progestin Replacement Study

2000 • 716 citations

Effects of Estrogen plus Progestin on Health-Related Quality of Life

2003 • 686 citations

Estrogen plus Progestin and Colorectal Cancer in Postmenopausal Women

2004 • 638 citations

Glycemic Effects of Postmenopausal Hormone Therapy: The Heart and Estrogen/progestin Replacement Study: A Randomized, Double-Blind, Placebo-Controlled Trial

2003 • 616 citations

Noncardiovascular disease outcomes during 6.8 years of hormone therapy : Heart and Estrogen/Progestin Study fellow-up (HERS II)

2002 • 578 citations

Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis

1999 • 577 citations

Effects of Hormone Replacement Therapy and Antioxidant Vitamin Supplements on Coronary Atherosclerosis in Postmenopausal Women

2002 • 570 citations

Noncardiovascular Disease Outcomes During 6.8 Years of Hormone Therapy

2002 • 569 citations

Effects of Estrogen Plus Progestin on Gynecologic Cancers and Associated Diagnostic Procedures<SUBTITLE>The Women's Health Initiative Randomized Trial</SUBTITLE>

2003 • 532 citations

Hormone Replacement Therapy and Prevention of Nonvertebral Fractures

2001 • 521 citations

Hormone Therapy and the Progression of Coronary-Artery Atherosclerosis in Postmenopausal Women

2003 • 376 citations

Noncardiovascular disease outcomes during 6.8 years of hormone therapy. heart and estrogen/progestin replacement study follow-up (HERS II)

2002 • 342 citations

Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial

2002 • 329 citations

A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT Atherosclerosis Study

2002 • 265 citations

Increased risk of recurrent venous thromboembolism during hormone replacement therapy--results of the randomized, double-blind, placebo-controlled estrogen in venous thromboembolism trial (EVTET).

2000 • 265 citations

Increased Risk of Recurrent Venous Thromboembolism during Hormone Replacement Therapy

2000 • 169 citations

A Clinical Trial of Estrogen-Replacement Therapy After Ischemic Stroke

2002 • 128 citations

The effectiveness and cost-effectiveness of ultrasound locating devices for central venous access: a systematic review and economic evaluation

2003 • 119 citations

Estrogen Plus Progestin and the Risk of Peripheral Arterial Disease

2004 • 76 citations

Can randomised trials rely on existing electronic data? A feasibility study to explore the value of routine data in health technology assessment

2003 • 70 citations

Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women. A randomized controlled trial

2003 • 54 citations

The randomized world is not without its imperfections: reflections on the Women’s Health Initiative Study

2002 • 44 citations

WISDOM: history and early demise - was it inevitable?

2002 • 42 citations

Blinding decreased recruitment in a prevention trial of postmenopausal hormone therapy

2004 • 32 citations

More Evidence Links NSAID, Estrogen Use With Reduced Alzheimer Risk

1996 • 26 citations

Study of completeness of registration at the Estonian cancer registry

2003 • 21 citations

Treatment adherence in the Estonian postmenopausal hormone therapy (EPHT) trial [ISRCTN35338757]

2005 • 15 citations

848-3 Estrogen plus progestin and the risk of peripheral arterial disease

2004 • 14 citations

Hormone replacement therapy in postmenopausal women: Utilization of health care resources by new users

2001 • 14 citations

Comparison of Estonian and Finnish physicians’ opinions of menopause and hormone therapy

2004 • 12 citations

WISDOM: history and early demise – was it inevitable?

2002 • 8 citations